Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: An AGEO randomised phase II study (FIRGEM)
Keywords: شیمیدرمانی مرحله ای; Sequential chemotherapy; Pancreatic cancer; FOLFIRI.3;